MANHATTAN BIOSOLUTIONS, LLC — National Science Foundation SBIR Phase I: BT
MANHATTAN BIOSOLUTIONS, LLC — SBIR Phase I award from National Science Foundation.
- Amount
- $256,000
- Agency
- National Science Foundation
- Program / Phase
- SBIR · Phase I
- Topic
- BT
- NAICS
- —
- Place of performance
- NJ
- Period
- 2020-09-01 → 2021-08-31
Description
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is to develop a safe and affordable COVID-19 vaccination technology, with broader utility in managing other contagious diseases. The new platform is